These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12476006)

  • 1. Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models.
    Lotte C; Patouillet C; Zanini M; Messager A; Roguet R
    Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():18-30. PubMed ID: 12476006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study.
    Schäfer-Korting M; Bock U; Diembeck W; Düsing HJ; Gamer A; Haltner-Ukomadu E; Hoffmann C; Kaca M; Kamp H; Kersen S; Kietzmann M; Korting HC; Krächter HU; Lehr CM; Liebsch M; Mehling A; Müller-Goymann C; Netzlaff F; Niedorf F; Rübbelke MK; Schäfer U; Schmidt E; Schreiber S; Spielmann H; Vuia A; Weimer M
    Altern Lab Anim; 2008 May; 36(2):161-87. PubMed ID: 18522484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol.
    Dreher F; Patouillet C; Fouchard F; Zanini M; Messager A; Roguet R; Cottin M; Leclaire J; Benech-Kieffer F
    Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():31-9. PubMed ID: 12476007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration.
    Engesland A; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2015 Mar; 104(3):1119-27. PubMed ID: 25558045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study.
    Schäfer-Korting M; Bock U; Gamer A; Haberland A; Haltner-Ukomadu E; Kaca M; Kamp H; Kietzmann M; Korting HC; Krächter HU; Lehr CM; Liebsch M; Mehling A; Netzlaff F; Niedorf F; Rübbelke MK; Schäfer U; Schmidt E; Schreiber S; Schröder KR; Spielmann H; Vuia A
    Altern Lab Anim; 2006 Jun; 34(3):283-94. PubMed ID: 16831060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses.
    Dreher F; Fouchard F; Patouillet C; Andrian M; Simonnet JT; Benech-Kieffer F
    Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():40-58. PubMed ID: 12476008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstructed skin kits: reproducibility of cutaneous irritancy testing.
    Faller C; Bracher M
    Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():74-91. PubMed ID: 12476011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstructed skin models as emerging tools for drug absorption studies.
    Küchler S; Strüver K; Friess W
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1255-63. PubMed ID: 23829446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral diffusion of ibuprofen in human skin during permeation studies.
    Schicksnus G; Müller-Goymann CC
    Skin Pharmacol Physiol; 2004; 17(2):84-90. PubMed ID: 14976385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of the experimental setup for skin absorption screening studies with reconstructed skin EPISKIN.
    Grégoire S; Patouillet C; Noé C; Fossa I; Benech Kieffer F; Ribaud C
    Skin Pharmacol Physiol; 2008; 21(2):89-97. PubMed ID: 18187968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for measuring in-vivo percutaneous absorption in humans.
    Kezic S
    Hum Exp Toxicol; 2008 Apr; 27(4):289-95. PubMed ID: 18684799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
    Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
    Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of various models for in vitro percutaneous absorption studies of ultraviolet filters.
    Huong SP; Bun H; Fourneron JD; Reynier JP; Andrieu V
    Skin Res Technol; 2009 Aug; 15(3):253-61. PubMed ID: 19630207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption.
    Schmook FP; Meingassner JG; Billich A
    Int J Pharm; 2001 Mar; 215(1-2):51-6. PubMed ID: 11250091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin.
    Tang H; Blankschtein D; Langer R
    J Pharm Sci; 2002 Aug; 91(8):1776-94. PubMed ID: 12115805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated human and animal stratum corneum as a partial model for the 15 steps of percutaneous absorption: emphasizing decontamination, part II.
    Hui X; Lamel S; Qiao P; Maibach HI
    J Appl Toxicol; 2013 Mar; 33(3):173-82. PubMed ID: 23112095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin absorption and human risk assessment.
    Poet TS; McDougal JN
    Chem Biol Interact; 2002 Apr; 140(1):19-34. PubMed ID: 12044558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of reconstructed skin models.
    Ponec M; Boelsma E; Gibbs S; Mommaas M
    Skin Pharmacol Appl Skin Physiol; 2002; 15 Suppl 1():4-17. PubMed ID: 12476005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of chemical dermal absorption by 14 natural products: a quantitative structure permeation analysis of components often found in topical preparations.
    Muhammad F; Jaberi-Douraki M; de Sousa DP; Riviere JE
    Cutan Ocul Toxicol; 2017 Sep; 36(3):237-252. PubMed ID: 27825281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.